Loading organizations...
§ Private Profile · Brooklyn, NY, USA
Synthetic biology firm creating microbial tags for food and agriculture supply chain traceability and food safety insurance.
Based in Brooklyn, New York, Aanika Biosciences develops synthetic biology-based microbial tagging technology that uses edible biological barcodes to track and authenticate products throughout agricultural supply chains. The company engineers food-grade spores to improve traceability, accelerate food recalls, and prevent contamination across the food and beverage sector. Additionally, the firm operates a subsidiary that provides commercial food safety and recall insurance, offering lower premiums to distributors and retailers who adopt their risk-mitigating tracking technology. The enterprise operates a 27,000-square-foot manufacturing facility supported by an $800,000 investment from the New York City Economic Development Corporation and has raised approximately $20 million in total venture funding. Aanika Biosciences is backed by institutional investors including Adjuvant Capital, Draper Associates, and SOSV, and maintains strategic partnerships with entities like Western Growers Insurance Services. The company was founded in 2018 by Vishaal Bhuyan and Ellen Jorgensen.
Aanika Biosciences has raised $14.0M across 2 funding rounds.
Aanika Biosciences has raised $14.0M in total across 2 funding rounds.
Aanika Biosciences is a biotechnology company founded in 2018 and headquartered in Brooklyn, New York, that develops microbial-based tags using synthetic biology to enhance food supply chain integrity, prevent contamination, and reduce losses for large food and agricultural companies.[1][2][3] It serves agribusinesses and food producers by addressing issues like spray drift, product contamination, and warranty programs, with solutions including property-damage coverage for herbicide drift currently under development; the company has raised $12 million in funding, including a recent seed round supporting Aanika Re, a Bermuda-based reinsurance vehicle approved by the Bermuda Monetary Authority to apply its tracking technology to insurance risks in agriculture.[2][4]
Aanika Biosciences was established in 2018 in Brooklyn, New York, focusing from the outset on synthetic biology innovations for food security.[2][3][5] Key early developments include creating microbial tags to track and trace products in supply chains, leading to pivotal milestones like securing $12 million in total funding and Bermuda Monetary Authority Sandbox approval for Aanika Re—a wholly-owned reinsurance entity leveraging this technology to mitigate agricultural risks such as prevention, identification, and insurance against losses.[1][2] Specific founder details are not publicly detailed in available sources, but the company's evolution from core tagging tech to reinsurance applications marks its growth trajectory.[2]
Aanika rides the wave of synthetic biology intersecting with agriculture and insurtech, capitalizing on rising demands for supply chain transparency amid global food security challenges like contamination outbreaks and climate-driven risks.[1][2] Timing aligns with post-2020 emphases on resilient agrotech, where microbial innovations enable non-chemical, precise tracking superior to RFID or chemical markers; market forces like escalating agricultural losses (trillions in potential insurance exposure) favor its reinsurance pivot.[2][4] By pioneering biotech in reinsurance via Bermuda's sandbox, Aanika influences the ecosystem, bridging startups with incumbents in a sector blending biology, data, and finance for broader adoption of bio-engineered risk tools.[2]
Aanika's reinsurance expansion via Aanika Re positions it to disrupt ag-insurance with scalable microbial tech, potentially capturing share in high-stakes markets as climate volatility amplifies drift and contamination claims.[2][4] Trends like AI-enhanced bio-tracking and regulatory sandboxes will accelerate growth, evolving its role from food security provider to ecosystem shaper in synth-bio agrotech. Watch for partnerships scaling warranty programs and global pilots, amplifying its supply chain integrity mission amid trillion-dollar opportunities.[1][2]
Aanika Biosciences has raised $14.0M in total across 2 funding rounds.
Aanika Biosciences's investors include Jonathan Cholak, Cygnus Capital, Draper Associates, SOSV, Tim Draper, Curious Capital, Norrsken VC, Operator Partners, Marco DeMeireles, Curtis Lee.
Aanika Biosciences has raised $14.0M across 2 funding rounds. Most recently, it raised $12.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2021 | $12M Series A | Jonathan Cholak | Cygnus Capital, Draper Associates, SOSV, TIM Draper | Announced |
| Nov 1, 2019 | $2M Seed | — | Curious Capital, Norrsken VC, Operator Partners, SOSV, Marco Demeireles, Curtis LEE | Announced |